You just read:

Janssen Announces Collaboration with Gilead to Develop PREZISTA®-based Single-tablet Regimen for the Treatment of People Living with HIV

News provided by

Janssen R&D Ireland Ltd

29 Dec, 2014, 13:30 GMT